Cerba Trova
Logo
Contact Us
Logo
Contact Us
Home » World Vaccine Congress Europe 2025

Cerba Research is proud to be part of the World Vaccine Congress Europe 2025 in Amsterdam, where we’ll showcase our end-to-end laboratory expertise in vaccine and virology research.

Visit Booth #400
Discover how our specialized services and global central laboratory network can support your vaccine development journey from early discovery to late-phase clinical trials.

Don’t miss our expert talk
Speaker: Marta Murreddu
Topic: Pandemic Readiness: Bridging Innovation and Clinical Implementation
Date & Time: Tuesday, 14 October • 15:45–16:15
Location: Pre-clinical Development, Track 3

Marta will highlight how, from early development through preclinical stages, our team accelerates pandemic response with rapid assay validation and specialized virological platforms.

Come and see our poster presentations
Presenter: Leon de Waal, Principal Scientist Preclinical Services
Poster title: Highly Pathogenic Avian Influenza Virus A/H5N1 subclade 2.3.4.4 b isolated from a European grey seal (Halichoerus grypus) is highly virulent in ferrets
Date & Time: Tuesday, 14 October • 13:30, Wednesday, 15 October • 13:45, Thursday 15 October • 11:30
Location: Poster Zone

Presenter: Aloys Tijsma, Senior Scientist
Poster title: Qualification of Microneutralization Assays for HMPV and HPIV-3: Robust Tools for Clinical Vaccine Evaluation
Date & Time: Tuesday, 14 October • 13:30, Wednesday, 15 October • 13:45, Thursday 15 October • 11:30
Location: Poster Zone

Let’s connect in Amsterdam and explore new possibilities together!

Meet our speaker

Marta Murreddu

Business Development Manager

Marta G. Murreddu is a seasoned project management professional in virology clinical research; successfully managing clinical trials, client communications, and ensuring adherence to timelines and budgets.

From 2021 to 2023, she led Clinical Virology Services at Viroclinics  (acquired by Cerba Research), where she managed teams, handled Phase 1–3 trials, and contributed to the Biosafety Committee. Additionally, she served as Study Director at Xplore, supervising pre-clinical biotechnical projects.

Marta holds a PhD in Microbiology from Università Cattolica and a Master’s in Biology from Università degli Studi di Cagliari. Her postdoctoral work, funded by Roche at Georgetown, focused on hepatitis B research, and she managed a BSL3 lab at Virginia Tech.

She has published extensively on antiviral effects and vaccine stability and holds certifications in Project Management and Lean Six Sigma. Her strong leadership and strategic skills contribute significantly to global health initiatives.

White paper – Decoding A BCR Fingerprint – Immune Repertoire Sequencing Publication – Africa: An Advantageous Landscape For Conducting Clinical Trials Whitepaper – Avoid Panic and be Prepared for the Next Pandemic Flyer – Immune Repertoire Sequencing: A Powerful Tool for Immune System Analysis White Paper – COVID-19 Therapy Development and Clinical Diagnostics – A Clinical Approach To A Multifaceted Evolving Disease Fact Sheet – Virology Center of Excellence: Illuminating Insights Into Infectious Diseases Brochure – Meeting the challenges you face with Global PBMC
Contact us

Reach out to our experts and discover how we are setting the standards to protect the world against infectious diseases.

© Copyright 2026
Socials
Socials